DE122005000049I1 - Neue Salzform von Pantoprazol - Google Patents

Neue Salzform von Pantoprazol

Info

Publication number
DE122005000049I1
DE122005000049I1 DE1999601840 DE69901840C DE122005000049I1 DE 122005000049 I1 DE122005000049 I1 DE 122005000049I1 DE 1999601840 DE1999601840 DE 1999601840 DE 69901840 C DE69901840 C DE 69901840C DE 122005000049 I1 DE122005000049 I1 DE 122005000049I1
Authority
DE
Germany
Prior art keywords
pantoprazole
salt form
new salt
new
dihydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE1999601840
Other languages
English (en)
Other versions
DE69901840D1 (de
DE122005000049I2 (de
DE69901840T2 (de
Inventor
Bernhard Kohl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Altana Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7881823&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE122005000049(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altana Pharma AG filed Critical Altana Pharma AG
Publication of DE122005000049I1 publication Critical patent/DE122005000049I1/de
Publication of DE122005000049I2 publication Critical patent/DE122005000049I2/de
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Manufacture And Refinement Of Metals (AREA)
  • Drying Of Gases (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
DE1999601840 1998-08-18 1999-08-12 Neue Salzform von Pantoprazol Active DE122005000049I2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843413A DE19843413C1 (de) 1998-08-18 1998-08-18 Neue Salzform von Pantoprazol
PCT/EP1999/005928 WO2000010995A1 (en) 1998-08-18 1999-08-12 Novel salt form of pantoprazole

Publications (2)

Publication Number Publication Date
DE122005000049I1 true DE122005000049I1 (de) 2006-12-28
DE122005000049I2 DE122005000049I2 (de) 2007-03-29

Family

ID=7881823

Family Applications (3)

Application Number Title Priority Date Filing Date
DE19843413A Expired - Fee Related DE19843413C1 (de) 1998-08-18 1998-08-18 Neue Salzform von Pantoprazol
DE69901840T Expired - Lifetime DE69901840T2 (de) 1998-08-18 1999-08-12 Neue salzform von pantoprazol
DE1999601840 Active DE122005000049I2 (de) 1998-08-18 1999-08-12 Neue Salzform von Pantoprazol

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DE19843413A Expired - Fee Related DE19843413C1 (de) 1998-08-18 1998-08-18 Neue Salzform von Pantoprazol
DE69901840T Expired - Lifetime DE69901840T2 (de) 1998-08-18 1999-08-12 Neue salzform von pantoprazol

Country Status (33)

Country Link
US (2) US6410569B1 (de)
EP (1) EP1105386B1 (de)
JP (1) JP2002523411A (de)
KR (1) KR100657835B1 (de)
CN (1) CN1146558C (de)
AT (1) ATE219074T1 (de)
AU (1) AU761715B2 (de)
BG (1) BG65255B1 (de)
BR (1) BR9914288A (de)
CA (1) CA2341031C (de)
CZ (1) CZ293734B6 (de)
DE (3) DE19843413C1 (de)
DK (1) DK1105386T3 (de)
EA (1) EA004431B1 (de)
EE (1) EE04278B1 (de)
ES (1) ES2178896T3 (de)
HK (1) HK1037616A1 (de)
HR (1) HRP20010117B1 (de)
HU (1) HU226618B1 (de)
IL (3) IL141328A0 (de)
ME (1) ME00562A (de)
MX (1) MXPA01001758A (de)
NO (1) NO319782B1 (de)
NZ (1) NZ509761A (de)
PL (1) PL198801B1 (de)
PT (1) PT1105386E (de)
RS (1) RS50071B (de)
SI (1) SI1105386T1 (de)
SK (1) SK285105B6 (de)
TR (1) TR200100287T2 (de)
UA (1) UA58605C2 (de)
WO (1) WO2000010995A1 (de)
ZA (1) ZA200100934B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol
MY137726A (en) 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
TW200410955A (en) 2002-07-29 2004-07-01 Altana Pharma Ag Novel salt of (S)-PANTOPRAZOLE
DE10234617B4 (de) * 2002-07-29 2013-04-04 Nycomed Gmbh Neues Salz von (S)-Pantoprazol
CA2510849A1 (en) * 2002-12-19 2004-07-08 Teva Pharmaceutical Industries Ltd Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
AU2004237362A1 (en) * 2003-05-06 2004-11-18 Altana Pharma Ag Proton pump inhibitors for the treatment of lower abdominal disorders
CL2004000983A1 (es) * 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
PE20050150A1 (es) * 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
CN1791406A (zh) * 2003-05-19 2006-06-21 普利瓦研究与发展有限公司 5－(二氟甲氧基)－2－[[(3,4－二甲氧基－2－吡啶基)甲基]亚硫酰基]－1h－苯并咪唑(泮托拉唑)钠水络合物的固态形式
EP1615913A2 (de) 2003-06-10 2006-01-18 Teva Pharmaceutical Industries Limited Verfahren zur herstellung von (pyridinyl)methyl]sulfinyl-substituierte benzimidazoles und neue chlorierte derivate von pantoprazole
WO2005012289A1 (en) * 2003-07-17 2005-02-10 Altana Pharma Ag Novel salt of (r) - pantoprazole
DK1651217T3 (da) * 2003-07-23 2008-06-16 Nycomed Gmbh Alkalisalte af protonpumpeinhibitorer
CN100457104C (zh) * 2003-07-23 2009-02-04 尼科梅德有限责任公司 质子泵抑制剂的碱性盐
CA2554260A1 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Calcium, potassium, zinc, lithium and aluminium salts of pantoprazole and (s)-pantoprazole
WO2005074898A2 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Composition comprising (s) pantoprazole and an antibiotic for treating helicobacter pylori
WO2005074932A1 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag The use of (s) - pantoprazole magnesium for the treatment of airway disorders
WO2005074930A1 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Pharmaceutical combinations of (s) -pantoprazole with nsaid or corticosteroids
WO2005074931A1 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Pharmaceutical combinations comprising (s) -pantoprazole
EP1716136A1 (de) * 2004-02-11 2006-11-02 Ulkar Kimya Sanayii Ve Ticaret A.S. Pyridin benzimidazol sulfoxide hoher reinheit
WO2005082888A1 (en) * 2004-03-01 2005-09-09 Milen Merkez Ilac Endustrisi A.S. Process for the preparation of magnesium salt of omeprazole
JP2007536349A (ja) * 2004-05-07 2007-12-13 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規の医薬剤形及び製造方法
WO2007041790A1 (en) * 2005-10-14 2007-04-19 Jon Pty Limited Salts of proton pump inhibitors and process for preparing same
WO2007146341A2 (en) 2006-06-12 2007-12-21 Teva Pharmaceutical Industries Ltd. Amorphous and crystalline forms of pantoprazole magnesium salt
WO2008057559A1 (en) * 2006-11-06 2008-05-15 Teva Pharmaceutical Industries Ltd. Processes for preparing substantially pure pantoprazole magnesium
EP3187494A1 (de) * 2015-12-30 2017-07-05 KRKA, tovarna zdravil, d.d., Novo mesto Verfahren zur herstellung von pantoprazole natrium sesquihydrat
EP3397630B1 (de) * 2015-12-30 2021-05-26 KRKA, tovarna zdravil, d.d., Novo mesto Verfahren zur herstellung von pantoprazole natrium sesquihydrat

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
DE4018642C2 (de) * 1990-06-11 1993-11-25 Byk Gulden Lomberg Chem Fab Neue Salzform des 5-Difluormethoxy-2-[(3,4-dimethoxy-2-pyridyl) methylsulfinyl]-1H-benzimitazol-Natriumsalzes
YU48263B (sh) * 1991-06-17 1997-09-30 Byk Gulden Lomberg Chemische Fabrik Gmbh. Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
SE508669C2 (sv) * 1996-04-26 1998-10-26 Astra Ab Nytt förfarande
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol

Also Published As

Publication number Publication date
BR9914288A (pt) 2001-06-19
TR200100287T2 (tr) 2001-07-23
HUP0103257A3 (en) 2003-01-28
EA200100208A1 (ru) 2001-08-27
US6686379B2 (en) 2004-02-03
CA2341031C (en) 2006-04-04
CA2341031A1 (en) 2000-03-02
KR100657835B1 (ko) 2006-12-15
BG105173A (en) 2001-11-30
ME00562B (me) 2011-12-20
HRP20010117B1 (en) 2010-07-31
DE19843413C1 (de) 2000-03-30
AU5515699A (en) 2000-03-14
SK2362001A3 (en) 2001-09-11
NO20010718L (no) 2001-02-12
US6410569B1 (en) 2002-06-25
EE200100054A (et) 2002-06-17
PT1105386E (pt) 2002-11-29
MXPA01001758A (es) 2002-04-17
RS50071B (sr) 2009-01-22
NO20010718D0 (no) 2001-02-12
EA004431B1 (ru) 2004-04-29
NO319782B1 (no) 2005-09-12
ZA200100934B (en) 2002-03-04
CN1146558C (zh) 2004-04-21
HU226618B1 (en) 2009-04-28
CN1318065A (zh) 2001-10-17
IL141328A0 (en) 2002-03-10
DK1105386T3 (da) 2002-09-30
WO2000010995A1 (en) 2000-03-02
EP1105386A1 (de) 2001-06-13
HUP0103257A2 (hu) 2002-02-28
IL141157A0 (en) 2002-02-10
ES2178896T3 (es) 2003-01-01
KR20010072487A (ko) 2001-07-31
US20020188008A1 (en) 2002-12-12
DE69901840D1 (de) 2002-07-18
BG65255B1 (bg) 2007-10-31
ME00562A (en) 2011-12-20
DE122005000049I2 (de) 2007-03-29
DE69901840T2 (de) 2003-05-22
NZ509761A (en) 2003-08-29
CZ293734B6 (cs) 2004-07-14
EE04278B1 (et) 2004-04-15
JP2002523411A (ja) 2002-07-30
AU761715B2 (en) 2003-06-05
ATE219074T1 (de) 2002-06-15
PL198801B1 (pl) 2008-07-31
YU11301A (sh) 2003-12-31
UA58605C2 (uk) 2003-08-15
SI1105386T1 (en) 2002-12-31
IL141157A (en) 2007-06-17
HRP20010117A2 (en) 2002-02-28
SK285105B6 (sk) 2006-06-01
HK1037616A1 (en) 2002-02-15
EP1105386B1 (de) 2002-06-12
PL345993A1 (en) 2002-01-14
CZ2001621A3 (cs) 2001-08-15

Similar Documents

Publication Publication Date Title
ATE219074T1 (de) Neue salzform von pantoprazol
TR200000782T2 (tr) Resorsinol türevleri.
DE122012000017I1 (de) Neuartige form von s-omeprazol.
DE69941116D1 (de) G von gdf-8
DE60039296D1 (de) System zur bestimmung der endgültigen position von zähnen
DE60114634D1 (de) Neue zusammensetzungen von minoxidil
ID29021A (id) Komposisi galantamina pelepasan terkontrol
DE60126838D1 (de) Amidoacetonitrile zur Bekämpfung von Endoparasiten
ATE236899T1 (de) Neue kristallinische form des kaliumsalzes des (s)-omeprazols
ATE274348T1 (de) Überbrückte indenopyrrolocarbazole
DE69907146D1 (de) Direkte oxidation von cycloalkanen
TR199903132A3 (tr) Metalosan bilesiklerinin aktive edici kompozisyonu.
SE9801494D0 (sv) Novel use
DE60008353D1 (de) Hemihydrat von 16.alpha.-bromoepiandrosterone
DE69416518D1 (de) Neue 9-n-bicyclische nucleosidverbindungen nützlich als selektive inhibitoren von proinflammatorische cytokinen
DE50003452D1 (de) Wässrige zusammensetzung zur filzfreiausrüstung von wolle
TR200003203T2 (tr) Karboksaldehitin saflaştırılması
TR199902605T2 (xx) Fibrinojenin azalt�lma y�ntemleri.
BR0110800A (pt) Polipeptìdeos antiangiogênicos
DK1131273T3 (da) 1,4-Diaryl-2-fluor-1-buten-3-olforbindelser og deres anvendelse til fremstilling af 1,4-diaryl-2-fluor-1,3-butadien- og 1,4-diaryl-2-fluor-2-butenforbindelser
ID19319A (id) Metoda yang diperbaiki untuk pembuatan mikrogel-mikrogel polialuminosilikat berkonsentrasi rendah
IT1305242B1 (it) Preparatore di mazzi di pelli.